Nabumetone 50228-0465
Product NDC
50228-0465- Manufacturer
- Sciegen Pharmaceuticals Inc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 26, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA078420
Need to source Nabumetone? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nabumetone | 500 mg/1 |
Drug Class
Nonsteroidal Anti-inflammatory Drug [EPC]Anti-Inflammatory AgentsNon-Steroidal [CS]
Packaging Options(3)
100 TABLET in 1 BOTTLE (50228-465-01)
500 TABLET in 1 BOTTLE (50228-465-05)
30 TABLET in 1 BOTTLE (50228-465-30)